Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:GEHC News 7 December 2025

GE HealthCare Technologies Inc (GEHC): AI Imaging Surge, Intelerad Deal and 2026 Stock Forecasts – Latest News as of December 7, 2025

GE HealthCare Technologies Inc (GEHC): AI Imaging Surge, Intelerad Deal and 2026 Stock Forecasts – Latest News as of December 7, 2025

Updated December 7, 2025 GE HealthCare Technologies Inc (Nasdaq: GEHC) is closing out 2025 with a flurry of announcements that signal an aggressive pivot toward AI-powered imaging, cloud software and long-term clinical alliances. From a $2.3 billion deal to acquire imaging software specialist Intelerad, to new NVIDIA-powered scanners and multi-year partnerships with the Mayo Clinic and the University of Rochester Medical Center, the company is trying to redefine itself as a digital-first medtech platform as it heads into 2026. GE HealthCare+3Reuters+3Yahoo Finance+3 At the same time, GE HealthCare has delivered better‑than‑expected third‑quarter earnings, raised its 2025 profit outlook and attracted
7 December 2025
····

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop